| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |